Home / Quetiapine / Ireland
IE ATC N05AH04 · updated 2 Nov 2026
Quetiapine shortage in Ireland
Is there a Quetiapine shortage in Ireland?
Yes. As of 2 Nov 2026, 15 Quetiapine products are reported short in Ireland, the first since 27 May 2024. The company estimate for the return is 6 Nov 2026 (latest 30 Jan 2027). Main reason: manufacturing problem.
Also short in Canada, Germany, France, Italy, Spain, Austria, Belgium, Czechia, Norway, Sweden, Australia. All countries.
Affected products in Ireland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IE | Quetex XR 300 mg prolonged-release tablets | Rowex Limited, | 27 May 2024 | 30 Jan 2027 | Manufacturing problem Manufacturing delay |
| IE | Quetex XR 200 mg prolonged-release tablets | Rowex Limited, | 3 Feb 2025 | 30 Jan 2027 | Manufacturing problem Manufacturing delay |
| IE | Quetex XR 50 mg prolonged-release tablets | Rowex Limited, | 24 Mar 2025 | 30 Jan 2027 | Manufacturing problem Manufacturing delay |
| IE | Tevaquel XL 300 mg Prolonged-release tablets | Teva Pharma B.V. | 30 Jun 2025 | 6 Nov 2026 | Manufacturing problem Manufacturing delay |
| IE | Notiabolfen XL 200 mg prolonged-release Tablet | Accord Healthcare Ireland Ltd. | 1 Jul 2025 | not given | Manufacturing problem Manufacturing delay |
| IE | Notiabolfen XL 300 mg prolonged-release Tablet | Accord Healthcare Ireland Ltd. | 1 Jul 2025 | not given | Manufacturing problem Manufacturing delay |
| IE | Notiabolfen XL 400 mg prolonged-release Tablet | Accord Healthcare Ireland Ltd. | 1 Jul 2025 | not given | Manufacturing problem Manufacturing delay |
| IE | Tevaquel XL 50 mg prolonged-release tablets | Teva Pharma B.V. | 24 Nov 2025 | 20 Nov 2026 | Manufacturing problem Manufacturing delay |
| IE | Seroquel XR 150mg prolonged-release tablets | CHEPLAPHARM Arzneimittel GmbH | 1 Apr 2026 | 11 Nov 2026 | Increased demand Unexpected increased demand |
| IE | Seroquel XR 300mg prolonged-release tablets | CHEPLAPHARM Arzneimittel GmbH | 1 Jun 2026 | 30 Jan 2027 | Increased demand Unexpected increased demand |
| IE | Seroquel XR 400mg prolonged-release tablets. | CHEPLAPHARM Arzneimittel GmbH | 1 Jun 2026 | 31 Dec 2026 | Increased demand Unexpected increased demand |
| IE | Tevaquel XL 200 mg Prolonged-release tablets | Teva Pharma B.V. | 29 Sep 2026 | 20 Nov 2026 | Manufacturing problem Manufacturing delay |
| IE | Tevaquel XL 400 mg Prolonged-release tablets | Teva Pharma B.V. | 30 Sep 2026 | not given | Manufacturing problem Manufacturing delay |
| IE | Seropia XR 50 mg prolonged-release tablets | Clonmel Healthcare Ltd | 9 Oct 2026 | 1 Jan 2027 | Manufacturing problem Manufacturing delay |
| IE | Seroquel XR 50 mg prolonged-release tablets | CHEPLAPHARM Arzneimittel GmbH | 16 Oct 2026 | not given | Increased demand Unexpected increased demand |
Source
HPRA (Health Products Regulatory Authority). Official list. Shortages notified to the HPRA by marketing-authorisation holders; one row per pack.